{"id":"https://openalex.org/W2471480185","doi":null,"title":"Intralesional recombinant interferon alpha-2b in Peyronie's disease.","display_name":"Intralesional recombinant interferon alpha-2b in Peyronie's disease.","alternate_titles":[],"publication_year":2000,"publication_date":"2000-09-01","ids":{"openalex":"https://openalex.org/W2471480185","mag":"2471480185","pmid":"https://pubmed.ncbi.nlm.nih.gov/11037665"},"language":"en","primary_location":{"id":"pmid:11037665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11037665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archivos espanoles de urologia","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2471480185"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"R Astorga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Astorga","raw_affiliation_strings":["General Calixto Garc\u00eda Hospital, Havana, Cuba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General Calixto Garc\u00eda Hospital, Havana, Cuba","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081727805","display_name":"O Cantero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Cantero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036587761","display_name":"Daya Mar\u00eda Dinza Contreras","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Contreras","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029980047","display_name":"del R\u00edo-Mart\u00edn A","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A del R\u00edo-Mart\u00edn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013158534","display_name":"Violeta Labarta-Beceiro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Labarta-Beceiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001100182","display_name":"A Guti\u00e9rrez-Elv\u00edrez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Guti\u00e9rrez-Elv\u00edrez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082412954","display_name":"Lima-L\u00f3pez Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Lima-L\u00f3pez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111684534","display_name":"Pedro Antonio L\u00f3pez-Saura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P L\u00f3pez-Saura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"53","issue":"7","first_page":"665","last_page":"671"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13313","display_name":"Dupuytren's Contracture and Treatments","score":0.7343999743461609,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13313","display_name":"Dupuytren's Contracture and Treatments","score":0.7343999743461609,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.14659999310970306,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11815","display_name":"Urological Disorders and Treatments","score":0.09849999845027924,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peyronie-s-disease","display_name":"Peyronie's disease","score":1.0},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":0.9739999771118164},{"id":"https://openalex.org/keywords/intralesional-injection","display_name":"intralesional injection","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.843999981880188},{"id":"https://openalex.org/keywords/penile-plaque","display_name":"penile plaque","score":0.7289999723434448},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.7310000061988831},{"id":"https://openalex.org/keywords/anti-interferon-antibodies","display_name":"anti-interferon antibodies","score":0.7440000176429749},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9299701452255249},{"id":"https://openalex.org/C2779145901","wikidata":"https://www.wikidata.org/wiki/Q874586","display_name":"Peyronie's disease","level":3,"score":0.9180635213851929},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6699152588844299},{"id":"https://openalex.org/C2779929075","wikidata":"https://www.wikidata.org/wiki/Q184674","display_name":"Erectile dysfunction","level":2,"score":0.5513529181480408},{"id":"https://openalex.org/C2777786686","wikidata":"https://www.wikidata.org/wiki/Q58","display_name":"Penis","level":2,"score":0.5154526829719543},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.507935106754303},{"id":"https://openalex.org/C527108885","wikidata":"https://www.wikidata.org/wiki/Q835153","display_name":"Physical examination","level":2,"score":0.48394539952278137},{"id":"https://openalex.org/C2779662492","wikidata":"https://www.wikidata.org/wiki/Q468787","display_name":"Hematoma","level":2,"score":0.4814869165420532},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.47602134943008423},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44335564970970154},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.4171369969844818},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3940943777561188},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3482285737991333},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.2887806296348572},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010411","descriptor_name":"Penile Induration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015552","descriptor_name":"Injections, Intralesional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11037665","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11037665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archivos espanoles de urologia","raw_type":"Journal Article"},{"id":"mag:2471480185","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11037665","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2790576581","https://openalex.org/W1522385306","https://openalex.org/W2079059016","https://openalex.org/W1983831846","https://openalex.org/W2095739037","https://openalex.org/W1490700409","https://openalex.org/W2415626958","https://openalex.org/W1971465828","https://openalex.org/W2419363106","https://openalex.org/W1570494766"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"interferon":[3],"alpha-2b":[4],"(IFN)":[5],"in":[6,119,128,134,139,147,195,212],"the":[7,49,53,219,230,268],"treatment":[8,168,261],"of":[9,41,64,92,192,270,292,298],"Peyronie's":[10],"disease":[11,54],"(PD)":[12],"since":[13],"IFN":[14,65,203,235,260],"exerts":[15],"antifibrotic":[16],"action":[17],"through":[18],"collagen":[19],"synthesis":[20],"inhibition":[21],"and":[22,37,94,104,108,137,183,250,295],"fibrolysis":[23],"stimulation.":[24],"METHODS:":[25],"The":[26,207,272],"study":[27],"comprised":[28],"34":[29],"patients,":[30,294],"aged":[31],"31":[32],"to":[33,47,169,202,229,234,275],"63,":[34],"with":[35,123,281],"clinical":[36,143],"ultrasonographic":[38],"(US)":[39],"diagnosis":[40],"PD,":[42],"who":[43],"gave":[44],"their":[45],"consent":[46],"enter":[48],"study.":[50],"They":[51],"had":[52,199],"for":[55,71,223,267],"10.1":[56],"+/-":[57,163,171],"5.6":[58],"(2-22)":[59],"months.":[60],"Ten":[61],"million":[62],"IU":[63],"were":[66,111,237,246],"injected":[67],"intralesionally,":[68],"twice":[69],"weekly":[70],"14":[72],"weeks":[73],"or":[74,216],"less":[75],"if":[76],"there":[77],"was":[78,99,145,154,218],"complete":[79],"remission.":[80],"Clinical":[81,182],"evaluation":[82],"included":[83],"penis":[84],"angle":[85,131],"at":[86,132],"erection,":[87],"sexual":[88],"dysfunction":[89,117],"(pain,":[90],"possibility":[91],"intercourse)":[93],"palpable":[95,126],"plaque.":[96],"Plaque":[97,158],"size":[98,159],"evaluated":[100],"by":[101],"US.":[102],"Systemic":[103],"local":[105],"adverse":[106,210],"reactions,":[107,226],"anti-IFN":[109,257],"antibodies":[110],"monitored":[112],"as":[113],"well.":[114],"RESULTS:":[115],"Sexual":[116],"disappeared":[118],"19/24":[120],"(79.2%)":[121],"patients":[122,149,194,214],"this":[124],"disorder,":[125],"lesions":[127],"21/34":[129],"(62%),":[130],"erection":[133],"15/32":[135],"(47%),":[136],"pain":[138],"16/17":[140],"(94%).":[141],"Complete":[142],"response":[144,152],"achieved":[146,280],"16/34":[148],"(47%).":[150],"Ultrasonographic":[151],"rate":[153],"88%,":[155],"(53%":[156],"complete).":[157,206],"decreased":[160],"from":[161],"56.7":[162],"42.9":[164],"(median:":[165,174],"35.4)":[166],"before":[167],"12.7":[170],"22.6":[172],"mm2":[173],"0)":[175],"(p":[176],"<":[177],"0.00001;":[178],"Wilcoxon's":[179],"paired":[180],"test).":[181],"US":[184],"responses":[185],"correlated.":[186],"No":[187,254],"patient":[188,255],"showed":[189],"progression.":[190],"Eight":[191],"9":[193],"whom":[196],"other":[197,282],"treatments":[198],"failed":[200],"responded":[201],"therapy":[204],"(5":[205],"main":[208],"systemic":[209],"reaction":[211],"most":[213],"(mild":[215],"moderate)":[217],"flu-like":[220],"syndrome":[221],"expected":[222],"IFN.":[224],"Local":[225],"more":[227],"related":[228],"administration":[231],"procedure":[232],"than":[233,278],"itself,":[236],"small":[238],"hematoma":[239],"(10":[240],"patients),":[241],"edema":[242],"(3),":[243],"cysts":[244],"that":[245],"excised":[247],"surgically":[248],"(2),":[249],"venous":[251],"leak":[252],"(1).":[253],"developed":[256],"antibodies.":[258],"CONCLUSIONS:":[259],"can":[262],"be":[263,276],"a":[264],"suitable":[265],"option":[266],"management":[269],"PD.":[271],"results":[273],"appear":[274],"better":[277],"those":[279],"procedures.":[283],"Further":[284],"work":[285],"should":[286],"include":[287],"comparative":[288],"studies,":[289],"long-term":[290],"follow-up":[291],"treated":[293],"alternative":[296],"ways":[297],"administration.":[299]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2471480185","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-07-22T00:00:00"}
